Read + Share
Rhodin KE, Beasley G. Reply to: "Methodological Concerns Regarding: "Timing of Adjuvant Immunotherapy
in Stage III Melanoma, Does it Matter?"" by Ahlstrom. Ann Surg Oncol 2024 Oct 5. doi: 10.1245/s10434-024-16299.
PMID: 39369121
|
 |
|
Rhodin KE, Beasley G. Reply to: "Methodological Concerns Regarding: "Timing of Adjuvant Immunotherapy
in Stage III Melanoma, Does it Matter?"" by Ahlstrom. Ann Surg Oncol 2024 Oct 5. doi: 10.1245/s10434-024-16299.
PMID: 39369121
|
|
|
|